All News

Microscopic subinguinal varicocelectomy results in improvement of multiple semen parameters, with a natural pregnancy rate of 34% and an overall pregnancy rate of approximately 63%.

Medicare Part B charges and payments constitute a significant fraction of the typical urology practice’s income, and owners of these practices should be aware of the pertinent rules and regulations-and the consequences of failure to comply with them.

The Painters offer some suggestions on how to tackle phase II of ICD-10 coding.

One only needs to do a Google search for “testosterone clinic” to realize there’s an explosion of for-profit businesses branded as men’s health establishments, offering what sounds like the fountain of youth to men with “low T” and sexual dysfunction. Unless one of these practices is affiliated with an academic medical center or urology group, there’s a good chance urologists are not part of the picture.

The patient sued, alleging, that the urologist should not have performed surgery on the patient, and that the second bowel perforation should have been detected and repaired during the original operation. He also claimed he should not have been discharged from the hospital in 3 days.

A recent Urology Times article highlights some provocative work that suggests there might be a difference in the ability of the surgeon to respond to a surgical crisis depending on the surgical approach being used-standard laparoscopy or robot-assisted laparoscopy.

A crisis situation during minimally invasive urologic surgery is equally rare during either a robotic or a laparoscopic procedure. However, use of the robot may negatively impact the outcome of the event and particularly among healthier patients, according to the findings of a recent study.

Three urologists offer their takes on a single-payer health care system.

Urologist Henry Rosevear, MD, has put together a brief checklist for first-time attendees-and for veteran attendees as well.

Early transurethral fulguration may be a reasonable option for treatment of severe hemorrhagic radiation cystitis, according to Japanese urologists.

An increasing proportion of certifying and recertifying urologists are women, and they perform a disproportionate volume of female urology cases, researchers at Northwestern University in Chicago found.

"Money Matters" columnists Joel M. Blau, CFP, and Ronald J. Paprocki, JD, CFP, CHBC, discuss irrevocable life insurance trusts as well as what happens when someone dies without leaving a will.

Radium 223 dichloride (Ra 223 [Xofigo]) can be safely combined with abiraterone acetate (ZYTIGA) for the treatment of patients with metastatic castration-resistant prostate cancer with symptomatic bone metastases, and appears to result in decreased bone pain and improved quality of life, according to the interim results of an open-label prospective study known as eRADicAte.

Urology Times SUO internship program member Cory Hugen, MD, reports on a recent Mayo Clinic study on familial history’s impact on post-RP outcomes and survival.

A leader in urologic oncology discusses four currently available molecular tests in this report from Urology Times SUO internship program member Brandon Manley, MD.

In a recently published study, researchers analyzed data from nearly 20,000 high-risk prostate cancer patients at more than 1,000 facilities.

Findings from a recent study emphasize the need for imaging with CT or MRI and bone scan to determine the pattern of spread in men with advanced prostate cancer.

Physician assistant Lisa Kerr, PA-C, shares techniques for improved patient understanding and care.

Since graduating from medical school, one of the most prevalent commentaries I have heard about health policy is “Fee-for-service is going away.” Depending on the commentator’s level of cynicism, that would be followed with either “You won’t be able to make a living in medicine anymore” or the milder “It’ll be interesting to see what happens.” Read more on Dr. Kaplan's insight on fee-for-service and what it means.

Every year, September through January is both an exciting and anxious time for fourth-year medical students and urology residency programs alike. With the conclusion of the 2016 urology match season this past January, I felt the same exhilaration that I did just 3 years ago. This year, however, I had the privilege to reflect on the demanding application process from the lens of an interviewer rather than that of an interviewee. Read more from Nirmish Singla, MD

Urologists should never feel as though they do not or cannot influence decisions that impact their patients and profession. Martin K. Dineen, MD, shares his insighst on the latest changes in government regulations, payer policies, and how you can get involved and make a difference.

During my second year as a urology resident, I walked into my mid-year evaluation meeting with my chairman, threw my hands up in the air, and told him I wasn’t happy with how I was operating. When I later reviewed my chairman’s dictated letter regarding our meeting, he wrote, “She has a lot of self-awareness.” While the remainder of the letter was also very complimentary, this single phrase really stuck out and was perhaps the most meaningful comment in the document. Learn more about Dr. Amy Pearlman's journey to becoming self-aware and why it's important.

Check out the latest products. From an MRI System that improves lesion conspicuity, a biopsy device receives FDA clearance and an App that tracks stent implants.

Peter C. Black, MD, discusses the current state of immune checkpoint inhibition for bladder cancer in this article from Urology Times SUO internship program member William Parker, MD.

Urology Times SUO internship program member Robert M. Turner, II, MD, reports on a recent presentation by J. Stuart Wolf, Jr., MD, about possible pitfalls of renal mass biopsy.

Lower urinary tract symptoms (LUTS) are not just a problem with staying asleep. Difficulty with sleep may actually impact LUTS, say researchers at Baylor College of Medicine in Houston.

Surveillance “should be more commonly used for patients with low-risk prostate cancer,” argues an author of the endorsement.